OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that it has entered into a two-year contract with Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business, to supply strontium-82, a cyclotron based medical isotope produced both at Nordion’s Vancouver, British Columbia and Ottawa, Ontario facilities.
Help employers find you! Check out all the jobs and post your resume.
